Azor and Orchitis - a phase IV clinical study of FDA data
Summary:
Orchitis is reported as a side effect among people who take Azor (amlodipine besylate; olmesartan medoxomil), especially for people who are 50-59 old, also take Lyrica, and have Multiple myeloma.
The phase IV clinical study analyzes which people have Orchitis when taking Azor. It is created by eHealthMe based on reports of 3,584 people who have side effects when taking Azor from the FDA, and is updated regularly.
What is Azor?
Azor has active ingredients of amlodipine besylate; olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 3,922 Azor users. Check the latest studies of Azor.
What is Orchitis?
Orchitis (inflammation of the testes) is found to be associated with 178 drugs and 459 conditions by eHealthMe. Check the latest studies of Orchitis.
3,584 people reported to have side effects when taking Azor.
Among them, 15 people (0.42%) have Orchitis.

Among these 15 people:
What is the age of people who have Orchitis when taking Azor? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 90 %
- 60+: 10 %
What are other drugs people take besides Azor? *
- Zometa: 15 people, 100.00%
- Fish Oil: 15 people, 100.00%
- Clonidine: 15 people, 100.00%
- Neurontin: 15 people, 100.00%
- Morphine Sulfate: 15 people, 100.00%
- Metoprolol Tartrate: 15 people, 100.00%
- Megace: 15 people, 100.00%
- Medrol: 15 people, 100.00%
- Colace: 15 people, 100.00%
- Lyrica: 15 people, 100.00%
What are other side effects people have besides Orchitis? *
- Hypocalcaemia (levels of calcium in blood serum are abnormally low): 15 people, 100.00%
- Hypoaesthesia (reduced sense of touch or sensation): 15 people, 100.00%
- Fungal Nail Infection: 15 people, 100.00%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 15 people, 100.00%
- General Physical Health Deterioration (weak health status): 15 people, 100.00%
- Glycosylated Haemoglobin Increased: 15 people, 100.00%
- High Blood Cholesterol: 15 people, 100.00%
- Hydrocele: 15 people, 100.00%
- Hyperlipidaemia (presence of excess lipids in the blood): 15 people, 100.00%
- Wheezing (a high-pitched whistling sound made while you breath): 15 people, 100.00%
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 15 people, 100.00%
- Pyogenic Liver Abscess (liver abscess caused by bacteria): 1 person, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Azor and have Orchitis?
- Check whether Orchitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Azor:
- Azor (3,922 reports)
Orchitis treatments and more:
- Orchitis (1,605 reports)
How severe was Orchitis and when was it recovered:
Expand to all the drugs that have ingredients of amlodipine besylate; olmesartan medoxomil:
Sub-studies by age:
0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Azor:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Orchitis:
- Orchitis (178 drugs)
Browse all the conditions that are associated with Orchitis:
- Orchitis (459 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on amlodipine besylate; olmesartan medoxomil (the active ingredients of Azor) and Azor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Verapamil Hydrochloride cause Ventricular Fibrillation? - now
- Could Omeprazole cause Generalised Erythema? - 4 seconds ago
- Hydrea vs. Coumadin, side effect and effectiveness comparison - 14 seconds ago
- Pemphigus and drugs of ingredients of ibuprofen - 15 seconds ago
- Alendronic Acid and Gastritis - Chronic for Women aged 60+ - 16 seconds ago
- Alendronic Acid and Chronic Gastritis for Women aged 60+ - 16 seconds ago
- Drug Eruption and drugs of ingredients of atezolizumab - 18 seconds ago
- Drug interactions of Amlodipine Besylate and Mycophenolate Mofetil - 32 seconds ago
- Could Remeron cause Gynecomastia? - 34 seconds ago
- Joint Swelling and drugs of ingredients of furosemide - 41 seconds ago